Company Number: 13125498

Analysis Date: 2025-07-20 13:41 UTC

Financial Health Assessment for MISSION AUTONOMY LTD

---

1. Financial Health Score: D

Explanation:
The company exhibits signs of financial distress with a negative net asset position that has worsened over recent years, sharply reduced cash reserves, and current liabilities exceeding current assets by a significant margin. While the company remains active and has director support, the balance sheet shows symptoms akin to a patient with chronic illness needing intervention to avoid further deterioration.

---

2. Key Vital Signs

Metric	2024 (Latest)	Interpretation
Cash at bank	£90	Critically low cash reserves; very limited liquidity to cover immediate expenses.
Current Liabilities	£2,134	Current debts remain, though greatly reduced from prior year.
Net Assets (Shareholders’ Deficit)	-£2,044	Negative equity indicates liabilities exceed assets, reflecting accumulated losses.
Share Capital	£100	Minimal capital base, typical for a small start-up or early-stage company.
Working Capital (Cash - Current Liabilities)	-£2,044	Negative working capital signaling potential short-term liquidity issues.
Trend in Net Assets	-£1,268 (2023) to -£2,044 (2024)	Worsening net asset position year on year, a symptom of ongoing losses or insufficient profitability.
Accruals & Deferred Income	£913	Significant portion of liabilities are deferred income, indicating prepayments from customers or grants received in advance.

---

3. Diagnosis

• Liquidity Symptoms: The company’s cash reserves have plummeted from over £31k in 2023 to just £90 in 2024, a stark warning sign of poor cash flow or heavy cash outflows. This is akin to a patient suddenly losing vital fluids — immediate attention is required to restore liquidity.

• Balance Sheet Weakness: Negative net assets show the company is technically insolvent on a balance sheet basis. This situation often indicates accumulated losses exceeding the initial investment and retained earnings deficit. Without corrective measures, this can impair the company’s ability to secure external finance or trade on favorable terms.

• Revenue Recognition/Deferred Income: The presence of deferred income (accruals) suggests the company has received funds or grants in advance, which is a positive sign that some cash inflows are expected or have been received for future work. However, this also implies obligations to deliver goods/services or meet grant conditions.

• Going Concern Note: The director’s statement mentions full financial assistance from the director to meet liabilities, which currently supports the company’s survival. This external "lifeline" is crucial but not a sustainable long-term solution.

• Size and Activity: The company is a small private limited entity focused on research and engineering design activities, likely in early development or R&D phase. Such businesses often experience losses initially as they invest in product development before generating revenue.

---

4. Recommendations

• Restore Healthy Cash Flow: Immediate focus on improving cash inflows is critical. This could include accelerating invoicing, securing short-term loans or director loans, or seeking grants/funding aligned with their R&D activities. Cash flow management must be closely monitored to avoid a liquidity crisis.

• Cost Control: Review and reduce discretionary spending to preserve cash. Since the average staff number is 1 (the director), overheads might be low, but all expenses should be scrutinized.

• Capital Injection: Consider increasing share capital or obtaining new equity investment to improve net asset position and provide a buffer against losses. This will strengthen the financial “immune system” against external shocks.

• Revenue Generation and Grant Utilization: Ensure that deferred income and grants are properly utilized to generate deliverables and future revenue streams. Developing a clear path to profitability through commercializing innovations or engineering services is essential.

• Financial Reporting and Monitoring: Although accounts are unaudited, consider engaging with an accountant or financial advisor to prepare forecasts, budgets, and cash flow projections. Early detection of financial “symptoms” will allow timely intervention.

• Strategic Review: Given the negative equity trend, the company should evaluate its business model, market opportunities, and operational strategies to pivot if necessary to improve financial health.

---

Executive Summary